ENETS studies


ENETS is proud to announce that the ENETS-endorsed study SurvivApp entitled “hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1–2 cm in size: a retrospective, Europe-wide, pooled cohort study” has recently been published in Lancet Oncology.

The aim of the present project was to evaluate the frequency of distant metastases and clinically relevant relapse and mortality, respectively, of aNEN (Neuroendocrine Neoplasms of the Appendix) measuring 1 - 2 cm.

ENETS congratulates and thanks all those who have been working on this study and is delighted to have been able to extend its support.

Read more about the publication (Jan 2023)

For more information, please click on the link below.